Last reviewed · How we verify
AERO-002
At a glance
| Generic name | AERO-002 |
|---|---|
| Also known as | Part 1 |
| Sponsor | AeroRx Therapeutics Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Phase 1/Phase 2a Study of AERO-007 Inhalation Solution, a Nebulized LABA/LAMA Combination for Maintenance Treatment of COPD (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- AERO-002 CI brief — competitive landscape report
- AERO-002 updates RSS · CI watch RSS
- AeroRx Therapeutics Inc. portfolio CI